Pfizer expects to be able to send data on the use of its COVID-19 vaccine in children to Health Canada by the end of the year.
Pfizer intends to submit data to Health Canada on trials of its COVID-19 vaccine in children under 12 by the end of the year, the company told Global News. In a statement, Pfizer said that it had completed its Phase 1 trial of the vaccine in children, which was designed to determine the optimal dose…